Journal Information

Article Information


Novel Synthesis of Thioflavones and Their Pyridyl Analogs from 2-Mercaptobenzoic(nicotinic) Acid


Expand AllCollapse All

Thioflavones have the skeleton of a thiochromen-4-one ring, which serves as a building block for biologically active molecules. Thioflavones have drawn much attention because of their various pharmacological activities such as antimalarial,1 antiviral,2 and antimicrobial activity.3 They also inhibit the proliferation of tumor cells4 while thioflavonoids, such as 3’,4’-dimethoxythioflavone, relax vascular contraction by activation of the EGF receptor.5

Several types of synthetic reactions for thioflavones and their heterocyclic analogs have been described in the literature.6 Among them, a tandem reaction using 2’-substituted chalcones and ynones allows for the efficient synthesis of thioflavones and their heterocyclic analogs. Three types of 2’-substituted chalcones, which were prepared from the condensation of arylaldehydes and 2’-substituted acetophenones, were converted to thioflavones by the following methods (Scheme 1(a)): (i) Treatment of 3-aryl-1-[2-(t-butyl-sulfanyl) phenyl]prop-2-en-1-ones with 3 equiv. iodine and NaHCO3 at reflux in EtCN.7 (ii) Cyclization of 2’-tosyloxy-chalcones with 5 equiv. sulfur in the presence of Et3N in DMSO at 80 °C.8 This method produced thioflavones together with (Z)-thioaurones as byproducts. (iii) Cu-catalyzed cyclization of 2’-iodo(bromo)chalcones using 2 equiv. potassium ethyl xanthogenate followed by the sequential oxidation of thioflavanone intermediates using H2SO4 in DMSO at 80 °C.9

The coupling of 2-(methylthio)benzoyl chlorides and arylacetylenes with 2.5 equiv. AlCl3 in CH2Cl2, followed by the addition of chloride, afforded the 2’-(methylthio)-β-chlorochalcone intermediates. These intermediates underwent sequential 1,4-addition of sulfur atom and demethylation by chloride anion to yield the thioflavones (Scheme 1(b)).10 Similarly, sequential addition of NaSH-elimination-SNAr reaction to 2’-halo-β-chlorochalcones, in the presence of 2 equiv. Cs2CO3 in DMSO at 140 °C, also afforded the thioflavones (Scheme 1(b)).11

On the other hand, the 1,4-addition of 1-(2-methoxyphenyl)-3-phenylprop-2-yn-1-ones with sodium sulfide nonahydrate produced 3-mercapto-1-(2-methoxyphenyl)-3-phenylprop-2-en-1-ones in DMSO at 80 °C, which underwent cycloaddition to yield thioflavones after re-aromatization (Scheme 1(c)).12 The heterocyclic analogs of thioflavones were also prepared by the addition of 1-(2-haloheteroaryl)-3-phenylprop-2-yn-1-ones to sodium hydrosulfide through sequential aromatic substitution at reflux in EtOH (Scheme 1(d)).13

A carbonylative coupling of 2-iodofluorobenzenes and arylacetylenes in CH3CN in the presence of 4 mol% Pd(OAc)2 and 8 mol% t-Bu3P·HBF4 under CO (5 bar), followed by the conjugate addition of sodium sulfide and SNAr substitution, afforded the thioflavones by a four-component reaction (Scheme 1(e)).14 Similarly, 1-bromo-2-fluorobenzenes were coupled with phenylacetylenes and tert-butyl isocyanide as a carbonyl source, in the presence of 3 mol% Pd(OAc)2 and 6 mol% bis[(2-diphenylphosphino)phenyl] ether (DPEPhos), in DMF at 100 °C to give the imino alkyne intermediates. These intermediates then underwent sodium sulfide nonahydrate addition, followed by hydrolysis with oxalic acid at reflux in THF, to yield the thioflavones (Scheme 1(e)).15 Thioflavones and their heterocyclic analogs were also synthesized by the three-component coupling of o-halo(hetero)aroyl chlorides with arylacetylenes, addition of sodium sulfide nonahydrate or sodium hydrosulfide, and subsequent cyclization at reflux in EtOH (Scheme 1(f)).16

Previous work

Scheme1.

Several methods for the synthesis of thioflavones and their heterocyclic analogs.

jkcs-65-166-f001.tif

Although several types of synthetic reactions for thioflavones have been reported, some of these methods have drawbacks including lack of regioselectivity during cyclization, byproducts, and harsh conditions. Recently, we reported that thioflavones were synthesized via 6-endo cyclization of 1-(2-benzylthio)phenyl-3-phenylprop-2-yn-1-ones derived from methyl 2-mercaptobenzoate.17 As an extension of our studies on the synthesis of thioflavones,13b,17,18 we report herein that thioflavones and their pyridyl analogs can be synthesized by 6-endo cyclization of 1-[(2-methylthio)phenyl]-3-phenylprop-2-yn-1-ones and 1-[(2-methylthio)pyridine-3-yl]-3-phenylprop-2-yn-1-ones using hydrobromic acid (Scheme 2).

This work

Scheme2.

Our approach for the synthesis of thioflavones and their pyridyl analogs.

jkcs-65-166-f002.tif

The treatment of 2-mercaptobenzoic acid (1) with 2 equiv. NaH in THF for 6 h at room temperature, followed by the addition of methyl iodide, afforded 2-(methylthio)benzoic acid (2) in 92% yield by selective S-methylation (Scheme 3). N-Methoxy-N-methyl 2-(methylthio)benzamide (5) was prepared by treating 2 with N-methoxy-N-methylcarbamoyl chloride and Et3N in the presence of 0.02 equiv. 4-(dimethylamino) pyridine (DMAP) in CH3CN. The reaction proceeded via carboxylic-carbamic anhydrides with the evolution of carbon dioxide for 1 h at room temperature, yielding 5 in 80% yield after a basic work-up and chromatographic separation. Thus, the synthesis of 5 from 1 was more effective than previous method17 by reducing reaction step.

Scheme3.

Reagents and conditions: (a) 2 equiv. NaH, rt, 6 h, THF; CH3I, overnight; (b) ClCON(OCH3)CH3, Et3N, 0.02 equiv. DMAP, CH3CN, rt, 1 h; (c) CH3OH (excess), 0.2 equiv. H2SO4, reflux, 48 h; (d) CH3(CH3O)NH2Cl, 2 equiv. iso-PrMgCl, THF, -10-0 °C, 1 h; (e) THF, 0 °C-rt, 1 h; (f) X = C: 2 equiv. 48 wt.% HBr, AcOH, rt, 1.5-2 h; rt, 24 h for 7b; 60 °C, 2 h for 7f; X = N: 3 equiv. 48 wt.% HBr, AcOH, 100 °C, 6-10 h.

jkcs-65-166-f003.tif

Methyl 2-(methylthio)nicotinate (4) was prepared by the reaction of 2-mercaptonicotinic acid (3) with an excess of CH3OH in the presence of 0.2 equiv. H2SO4 for 48 h at reflux. The esterification occurred together with the S-methylation of the thiol group under this condition.19 The S-methylation seemed to proceed by the nucleophilic substitution of the sulfur atom to a protonated methyloxonium cation. Thus, the two methyl groups of 4 were observed at δ 3.93/2.54 in 1H NMR and δ 52.3/13.9 ppm in 13C NMR spectra. The conversion of 3 to 4 has the advantage of avoiding additional S-methylation. Original attempt to S-methylation of 3 with methyl iodide using 2 equiv. of sodium hydride or lithium diisopropylamide was fruitless.

N-Methoxy-N-methyl 2-(methylthio)nicotinamide (6) was prepared by the slow addition of 2 equiv. iso-PrMgCl to a slurry solution of 4 and Me(OMe)NH2Cl in THF. The methoxy group of 4 was substituted by in situ Me(OMe)NMgCl for 1 h between -10 and 0 °C, yielding 6 in 90% yield after an acidic work-up and chromatographic separation. The acylation of 5 and 6 with (hetero) arylethynyllithiums in THF proceeded smoothly for 1 h between 0 °C and room temperature. After quenching with a 1 N HCl solution and an acidic work-up, the residue was purified by silica gel column chromatography to give 7 and 8 in 88-92% and 85-93% yields, respectively.

The 6-endo cyclization of 7 was carried out using 2 equiv. HBr in AcOH. The reaction proceeded smoothly for 1.5-2 h at room temperature and the competitive 5-exo cyclization was not observed. In contrast, the cyclization of 1-(2-methylthio)phenyl-3-(2-methoxyphenyl)prop-2-yn-1-one (7b) proceeded sluggishly for 24 h at room temperature, reflecting the steric effect of the o-methoxy group. After the evaporation of AcOH and a basic work-up, the residue was purified by silica gel column chromatography to give 9 in 80-88% yields. The cyclization of 1-[(2-methylthio)pyridine-3-yl]-3-phenylprop-2-yn-1-one (8a) was briefly screened with different acids and solvents. The reaction of 8a with 3 equiv. HCl, HBr, and HI in AcOH at 100 °C afforded 2-phenyl-4H-thiopyrano[2,3-b]pyridin-4-one (10a) in 72, 89, and 81% yield, respectively, after 24, 10, and 7 h, respectively. The cyclization of 8a with 3 equiv. HBr in CH3CN proceeded for 24 h at 80 °C to give 10a in 74% yield. Thus, the 6-endo cyclization of 8 was carried out using 3 equiv. HBr in AcOH at 100 °C and afforded 10 in 41-90% yields.

As shown in Table 1, various thioflavones and their pyridyl analogs were synthesized by the cyclization of 7 and 8 using HBr in AcOH. The regioselective cyclization of 7 and 8 worked well with both electron-donating (CH3, OCH3) and electron-withdrawing groups (Cl, Br) of the 2-substituted ring. Furthermore, the cyclization of 7 and 8 containing 3-pyridyl (7g) and 3-thienyl (8h) worked equally well to give 2-(3-pyridyl)-4H-1-benzothiopyran-4-one (9g) and 2-(3-thienyl)-4H-thiopyrano[2,3-b]pyridin-4-one (10h) in 80% and 88% yield, respectively.

Table1.

Synthesis of thioflavones (9) and 2-phenyl-4H-thiopyrano[2,3-b]pyridin-4-ones (10) from 7 and 8a

jkcs-65-166-t001.tif

a The reaction was carried out using 2 or 3 equiv. 48 wt.% HBr in AcOH.

In conclusion the present method provides a regioselective synthesis of thioflavones and their pyridyl analogs by 6-endo cyclization of 7 and 8, derived from 2-mercaptobenzoic(nicotinic) acid, using HBr in AcOH in high yields.

EXPERIMENTAL

Preparation of Thioflavone (9a)

To a solution of 1-[(2-methylthio)phenyl]-3-phenylprop-2-yn-1-one (7a, 252 mg, 1.0 mmol) in AcOH (15 mL) was added hydrobromic acid (48 wt.% in H2O, 227 μL, 2.0 mmol) and stirred for 1.5 h at room temperature. After evaporation of AcOH, the mixture was poured into a saturated NaHCO3 solution (20 mL) and extracted with methylene chloride (3×15 mL). The organic layer was dried over anhydrous MgSO4 and filtered. The concentrated residue was purified by silica gel column chromatography with 30% EtOAc/n-hexane to give 9a (203 mg, 85%). mp 125-126 °C; 1H NMR (300 MHz, CDCl3) δ 8.55 (d, J = 7.5 Hz, 1H), 7.62-7.71 (m, 4H), 7.55-7.61 (m, 1H), 7.48-7.55 (m, 3H), 7.24 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 180.9, 153.1, 137.7, 136.6, 131.6, 130.9, 130.8, 129.3, 128.6, 127.8, 127.0, 126.5, 123.5; FT-IR (KBr) 1615 (C=O) cm-1; Ms m/z (%) 238 (M+, 100).

Preparation of 2-phenyl-4H-thiopyrano[2,3-b]pyridin-4-one (10a)

To a solution of 1-[(2-methylthio)pyridine-3-yl]-3-phenylprop-2-yn-1-one (8a, 253 mg, 1.0 mmol) in AcOH (15 mL) was added hydrobromic acid (48 wt.% in H2O, 341 μL, 3.0 mmol) and the reaction mixture was heated at 70 °C to yield an homogeneous solution. The mixture was further stirred for 10 h at 100 °C and AcOH was then evaporated under reduced pressure. The mixture was poured into a saturated Na2CO3 solution (20 mL) and extracted with methylene chloride (3×15 mL). The organic layer was dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The product was isolated by silica gel column chromatography with 50% EtOAc/n-hexane to give 10a (213 mg, 89%). mp 121-123 °C; 1H NMR (300 MHz, CDCl3) δ 8.82 (dd, J = 4.5, 1.9 Hz, 1H), 8.77 (dd, J = 8.1, 1.9 Hz, 1H), 7.68-7.74 (m, 2H), 7.49-7.52 (m, 4H), 7.27 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 181.3, 159.1, 154.8, 152.8, 136.8, 136.3, 131.1, 129.4, 128.1, 127.0, 123.6, 123.0; FT-IR (KBr) 1617 (C=O) cm-1; Ms m/z (%) 239 (M+, 100).

Notes

References

1. 

R. K. Razdan R. J. Bruni A. C. Mehta K. K. Weinhardt Z. B. Papanastassiou J. Med. Chem.197821643 [CrossRef]

2. 

D. Zhang X. Ji R. Gao H. Wang S. Meng Z. Zhong Y. Li J. Jiang Z. Li Acta Pharm. Sin. B20122575 [CrossRef]

3. 

M. Jang G.-H. Kim J. Food Saf.201737e12337 [CrossRef]

4. 

[(a)] H.-K. Wang K. F. Bastow L. M. Cosentino K.-H. Lee J. Med. Chem.1996391975 [CrossRef] [(b)] T. Kataoka S. Watanabe E. Mori R. Kadomoto S. Tanimura M. Kohno Bioorg. Med. Chem.2004122397 [CrossRef]

5. 

E. J. Jang Y. M. Seok J. I. Lee H. M. Cho U. D. Sohn I. K. Kim Naunyn-Schmiedeberg’s Arch. Pharmacol.2013386339 [CrossRef]

6. 

For reviews, see: [(a)] V. Y. Sosnovskikh Russ. Chem. Rev.20188749 [CrossRef] [(b)] J. Dong Q. Zhang Q. Meng Z. Wang S. Li J. Cui Mini-Reviews Med. Chem.2018181714 [CrossRef]

7. 

K. Kobayashi A. Kobayashi K. Ezaki Heterocycles2012851997 [CrossRef]

8. 

S. Venkateswarlu G. N. Murty M. Satyanarayana V. Siddaiah Synth. Commun.2020502347 [CrossRef]

9. 

S. Sangeetha G. Sekar Org. Lett.20192175 [CrossRef]

10. 

H. Y. Kim E. Song K. Oh Org. Lett.201719312 [CrossRef]

11. 

D. Wang P. Sun P. Jia J. Peng Y. Yue C. Chen Synthesis2017494309 [CrossRef]

12. 

X. Yang S. Li H. Liu Y. Jiang H. Fu RSC Adv.201226549 [CrossRef]

13. 

[(a)] F. C. Fuchs G. A. Eller W. Holzer Molecules2009143814 [CrossRef] [(b)] J. I. Lee Bull. Kor. Chem. Soc.2012331375 [CrossRef]

14. 

C. Shen A. Spannenberg X.-F. Wu Angew. Chem. Int. Ed.2016555067 [CrossRef]

15. 

F.-L. Zhang Z.-B. Chen K. Liu Q. Yuan Q. Jiang Y.-M. Zhu Synlett201829621 [CrossRef]

16. 

[(a)] B. Willy T. J. J. Muller Synlett200920091255 [CrossRef] [(b)] B. Willy W. Frank T. J. J. Muller Org. Biomol. Chem.2010890 [CrossRef]

17. 

J. I. Lee J. Kor. Chem. Soc.202064239

18. 

[(a)] J. I. Lee Bull. Kor. Chem. Soc.200930710 [CrossRef] [(b)] J. I. Lee M. J. Kim Bull. Kor. Chem. Soc.2011321383 [CrossRef]

19. 

M. Shimizu T. Shimazaki Y. Kon T. Konakahara Heterocycles201081413 [CrossRef]